By PF Lewis (NaturalNews) When a corrupt medical group wants to discourage dissidence from within, it targets a high profile figure to disgrace. This intimidates others from doing the right thing if it disrupts the lies and profits of Big Pharma. Dr. Andrew Wakefield was a high profile scapegoat, smeared with lies from the media […]
Wakefield’s Autism Research Is Cited by Researchers Who Say They Can’t Replicate It
By Gaia Health Something rather strange is going on in autism research. Andrew Wakefield was smeared, his reputation trashed, his career torched, and his work labeled every negative thing conceivable—including fraud. The Lancet pulled his work off their site; they disappeared it. Everything conceivable was done to discredit Wakefield’s work and make it disappear. So why are […]
Study reveals altered digestive genes in children with autism and gastrointestinal disturbances
NEWS Medical Published on September 17, 2011 at 2:22 AM · Researchers at the Center for Infection and Immunity (CII) at Columbia University’s Mailman School of Public Health and at the Harvard Medical School report that children with autism and have altered expression of genes involved in digestion. These variations may contribute to changes in […]
A tablet a day keeps the patient at bay: the health hazards of prevention – vaccinations and pharmacoprophylaxis BSEM conference 11th March 2011
FoodsMatter.com ‘Do no harm! That’, said Dr David Freed, introducing the British Society of Environmental Medicine’s excellent conference which he had also organised, ‘is the charge put upon doctors when they qualify. But do they?’ The assumption is that the more medical care is available, the more good it will do but the facts do […]
Neuroprotection in the Newborn Infant
NIH
Pub Med Central
Clin Perinatol. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as:
Clin Perinatol. 2009 December; 36(4): 859–880.
doi: 10.1016/j.clp.2009.07.013.
Fernando F. Gonzalez, M.D.a and Donna M. Ferriero, M.D.ab
Synopsis
Neonatal brain injury is an important cause of death and disability, with pathways of oxidant stress, inflammation, and excitotoxicity that lead to damage that progresses over a long period of time. Therapies have classically targeted individual pathways during early phases of injury, but more recent therapies such as growth factors may also enhance cell proliferation, differentiation and migration over time. More recent evidence suggests combined therapy may optimize repair, decreasing cell injury while increasing newly born cells.
